We will further our investment into research to accelerate new treatments and investigate early-stage drug discovery and development.

We will broaden our clinical care network so the growing number of people with Parkinson’s will receive better quality of care no matter where they live.

We will ensure that people have access to the best programs and resources right in their own communities.